title: New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital, Belfast, Northern Ireland, UK. andrewcairns@doctors.org.uk
authors.forename: A P
authors.initials: AP
authors.lastname: Cairns
authors.forename: M K J
authors.initials: MK
authors.lastname: Duncan
authors.forename: A E
authors.initials: AE
authors.lastname: Hinder
authors.forename: A J
authors.initials: AJ
authors.lastname: Taggart
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins / Q000009:adverse effects
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000068800:Etanercept